WHO Grade III Glioma
|
disease |
Neoplasms
|
Neoplastic Process
|
10
|
|
0.020 |
None |
1.000 |
2 |
|
2012 |
2019 |
WHO Grade II Glioma
|
disease |
|
Neoplastic Process
|
11
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Well Differentiated Oligodendroglioma
|
disease |
Neoplasms
|
Neoplastic Process
|
270
|
22
|
0.400 |
None |
1.000 |
35 |
2
|
2009 |
2019 |
Vulvar Lichen Sclerosus
|
disease |
Female Urogenital Diseases and Pregnancy Complications
|
Disease or Syndrome
|
25
|
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Von Hippel-Lindau Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
174
|
187
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Visual seizure
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Disease or Syndrome
|
209
|
|
0.300 |
None |
1.000 |
1 |
|
2016 |
2016 |
Visceral angiomatosis
|
disease |
|
Disease or Syndrome
|
17
|
|
0.100 |
None |
|
0 |
|
|
|
Vertiginous seizure
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Disease or Syndrome
|
102
|
|
0.300 |
None |
1.000 |
1 |
|
2016 |
2016 |
Ventricular Dysfunction, Left
|
phenotype |
Cardiovascular Diseases
|
Pathologic Function
|
88
|
|
0.300 |
None |
1.000 |
1 |
|
2016 |
2016 |
Venous Thrombosis
|
phenotype |
Cardiovascular Diseases
|
Pathologic Function
|
117
|
218
|
0.100 |
None |
|
0 |
|
|
|
Venous Thromboembolism
|
phenotype |
Cardiovascular Diseases
|
Disease or Syndrome
|
378
|
408
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Vascular lesions
|
disease |
|
Disease or Syndrome
|
111
|
9
|
0.010 |
None |
1.000 |
1 |
2
|
2011 |
2011 |
Urothelial Carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
449
|
10
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Undifferentiated carcinoma of nasopharynx
|
disease |
|
Neoplastic Process
|
23
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Undifferentiated carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
283
|
8
|
0.030 |
None |
1.000 |
3 |
1
|
2017 |
2019 |
Unconjugated hyperbilirubinemia
|
disease |
Pathological Conditions, Signs and Symptoms
|
Disease or Syndrome
|
23
|
4
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2018 |
Tumors of Adrenal Cortex
|
group |
Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
74
|
5
|
0.100 |
None |
|
0 |
|
|
|
Tumor Progression
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Neoplastic Process
|
3865
|
72
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Tumor Initiation
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
533
|
8
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.040 |
None |
1.000 |
4 |
1
|
2017 |
2019 |
Tumor Angiogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Neoplastic Process
|
822
|
5
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Triple-Negative Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
1598
|
96
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Triple Negative Breast Neoplasms
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
1674
|
99
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Tonic Seizures
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Disease or Syndrome
|
108
|
|
0.300 |
None |
1.000 |
1 |
|
2016 |
2016 |
Tonic - clonic seizures
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Disease or Syndrome
|
300
|
32
|
0.300 |
None |
1.000 |
1 |
|
2016 |
2016 |